Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Alberta
$27,000.00
Limiting Glucose and Supplementing Ketones Enhances Heart Preservation During Ex-Situ Perfusion
EF 2025-26
Résumé
Heart failure (HF) remains a major global health challenge, with heart transplantation as the current gold standard therapy. Conventional donor heart preservation using static cold storage is limited by a short preservation window of 6 hours and minimal capacity for therapeutic intervention during transport. Ex situ heart perfusion (ESHP) extends preservation up to 12 hours and better maintains cardiac function by supplying oxygen and nutrients while supporting physiological conditions such as chamber pressure. However, functional decline is still observed during ESHP, and the mechanisms underlying this deterioration are not fully understood. We hypothesize that reliance on high glucose concentrations during ESHP may contribute to this decline. Traditional use of excess glucose can drive metabolic dysregulation, promoting oxidative stress and inflammation, which are consistently observed during ESHP runs. Ketone bodies (KB) are an alternative metabolic substrate with established benefits in HF, including improved metabolic efficiency, reduced oxidative stress, and decreased inflammation. In this study, pig hearts will undergo eight hours of ESHP with either high glucose or KB perfusates. Functional parameters, including heart rate, oxygen consumption, and electrolyte balance, will be continuously monitored. Post perfusion tissue samples will be analyzed for markers of metabolic stress and injury. This study will be the first to investigate the use of KB during ESHP, providing insights that may inform strategies to optimize perfusates for ex situ heart preservation. The resulting advances could also be applied to other organs preserved ex situ. Ultimately, these improvements may enhance cardiac function in transplantation and provide patients with higher quality hearts.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572686
Name
Hassanzadeh Parham
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Limiting Glucose and Supplementing Ketones Enhances Heart Preservation During Ex-Situ Perfusion
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiac Surgery; Ex Situ Heart Perfusion; Functional Decline; Glucose Metabolism; Heart Donation; Inflammation; Ketone Metabolism; Oxidative Stress; Porcine Model; Translational Research
Abstract
Heart failure (HF) remains a major global health challenge, with heart transplantation as the current gold standard therapy. Conventional donor heart preservation using static cold storage is limited by a short preservation window of 6 hours and minimal capacity for therapeutic intervention during transport. Ex situ heart perfusion (ESHP) extends preservation up to 12 hours and better maintains cardiac function by supplying oxygen and nutrients while supporting physiological conditions such as chamber pressure. However, functional decline is still observed during ESHP, and the mechanisms underlying this deterioration are not fully understood. We hypothesize that reliance on high glucose concentrations during ESHP may contribute to this decline. Traditional use of excess glucose can drive metabolic dysregulation, promoting oxidative stress and inflammation, which are consistently observed during ESHP runs. Ketone bodies (KB) are an alternative metabolic substrate with established benefits in HF, including improved metabolic efficiency, reduced oxidative stress, and decreased inflammation. In this study, pig hearts will undergo eight hours of ESHP with either high glucose or KB perfusates. Functional parameters, including heart rate, oxygen consumption, and electrolyte balance, will be continuously monitored. Post perfusion tissue samples will be analyzed for markers of metabolic stress and injury. This study will be the first to investigate the use of KB during ESHP, providing insights that may inform strategies to optimize perfusates for ex situ heart preservation. The resulting advances could also be applied to other organs preserved ex situ. Ultimately, these improvements may enhance cardiac function in transplantation and provide patients with higher quality hearts.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hassanzadeh, Parham
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~